We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Software Analyzes Mammograms with High Accuracy

By MedImaging International staff writers
Posted on 03 Jan 2022
Print article
Image: The Insight MMG algorithm at work (Photo courtesy of Lunit)
Image: The Insight MMG algorithm at work (Photo courtesy of Lunit)
A radiology artificial intelligence (AI) algorithm provides the location of lesions suspicious of breast cancer and an abnormality score that reflects the AI's confidence level.

The Lunit (Seoul, South Korea) Insight MMG algorithm is intended to aid detection, localization, and characterization of suspicious areas for breast cancer on 4-view Full-Field Digital Mammography (FFDM) images. The location of breast cancer is generated in the form of heatmaps and/or contour maps. The AI abnormality score, derived without human interpretation, reflects the probability of the existence of breast cancer, and also provides an assessment of breast density.

Major benefits include improved detection accuracy, reducing false-positive recalls by 14% and false-negative recalls by 18%; Automatic triage of up to 60% of the cases based on AI abnormality scores; improved reading performance by general radiologists, to a level of breast specialists; early diagnosis of T1 and node-negative breast cancer with 91% and 87% accuracy, respectively; decision-making support in complicated, hard-to-conclude cases classified as BI-RADS 3 or 4; and improved diagnostic accuracy for dense and fatty breasts by up to 9% and 22%, respectively.

“With our AI solution, we hope to increase the efficiency and accuracy of mammography screening. We can assist radiologists diagnose diseases at an earlier stage, helping patients be treated at the right time,” said Brandon Suh, CEO of Lunit. “We strongly believe that sooner or later AI will become the new standard of care, and AI will be used everywhere as a must-use product. Not only will it be used as a tool to make the workflow more efficient, but it will ensure better diagnosis and healthier life for patients.”

Related Links:
Lunit

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Acclarix AX9
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Ultrasound Needle Guide
Ultra-Pro II

Print article

Channels

Ultrasound

view channel
Image: The powerful machine learning algorithm can “interpret” echocardiogram images and assess key findings (Photo courtesy of 123RF)

Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function

Foundation models represent an exciting frontier in generative artificial intelligence (AI), yet many lack the specialized medical data needed to make them applicable in healthcare settings.... Read more

Nuclear Medicine

view channel
Image: The multi-spectral optoacoustic tomography (MSOT) machine generates images of biological tissues (Photo courtesy of University of Missouri)

New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure

Imaging inflammation using traditional radiological techniques presents significant challenges, including radiation exposure, poor image quality, high costs, and invasive procedures. Now, new contrast... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.